Women And Men Respond Equally To Medical Treatment For Coronary Artery Disease

April 29, 1996

ANAHEIM, CALIF. -- In the first analysis of gender differences in heart disease based on many studies, researchers at Duke University Medical Center have shown that women respond as well as men to medical treatment for heart disease.

The result dispels a growing concern among health policy makers that a woman's heart may not respond to drug treatment the same as a man's. It also means that physicians, who traditionally have not recognized heart disease as quickly in women, need to see women as candidates for the same type of therapies as men.

Duke researcher Leslee Shaw and cardiologist Dr. Robert Califf reported their results Wednesday at the 68th annual American Heart Association meeting.

"We know women have higher mortality rates than men from heart attack," Shaw said. "We can attribute most of the poorer outcome in women to the fact that most women with heart disease are, in general, older and sicker. But there still has been the nagging question of whether women should be getting a different treatment regimen."

Prior to this study, it had been difficult to gauge whether women and men get the same treatment benefit from any given drug in a clinical trial because large populations of patients must be enrolled in any study to satisfy statistical requirements for proof of treatment. Since most therapies for heart disease only reduce death rates moderately, the number of patients enrolled in any given study must be large -- several thousand people -- to see any gender differences in treatment. Few such studies have enrolled enough women to be able to accurately assess if women respond differently than men due to concerns about child-bearing potential or the advanced age of women with heart disease.

To overcome this problem, the Duke researchers pooled the results of 165 individual clinical trials in what is called a meta-analysis. They looked at the published results of clinical trials on all of the major classes of cardiovascular drugs, including the affects of aspirin therapy, the clot-busters t-PA and streptokinase, calcium channel blockers and beta blockers, among others. The researchers reasoned that pooling the results of many small studies would give an opportunity to observe statistical differences in response to treatment that looking at studies individually would not.

The combined studies included more than 46,000 women and almost 160,000 men with heart disease.

The results showed that in randomized, blinded clinical trials women and men respond equally to drug treatments.

"The key result here is that when the physician's judgment is taken out of the equation, women respond as well as men to a variety of drug treatments," Shaw said. "Observational studies have shown that in practice, women receive less treatment than men. Whether physicians can accurately identify risk of heart disease in women is still an issue. This analysis shows there is no reason to consider women with heart disease a separate group that must be treated differently."

The findings have implications for policy makers since there are initiatives at the federal level to mandate the inclusion of women in any clinical trial in proportion to their representation in the population. Such a mandate would make it much more difficult, time consuming and costly to carry out clinical trials on new drugs or treatment protocols, since fewer women than men have heart disease. In addition, it shows that even though some previous clinical trials have not included enough women to show a specific treatment affect, there is no reason to assume women won't benefit if the overall result showed a benefit, the researchers said.

"There is a growing concern among federal health care leaders that women, who have been under represented in clinical trials, may not get the same benefit as men from current treatments,"Califf said. "This study clearly sends a message that we should not withhold a treatment from women simply because it hasn't been proven effective expressly in women."
-end-


Duke University Medical Center

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.